Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
D. Projean, P.-E. Morin, T. M. Tu & J. Ducharme. (2003) Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N -demethylation in human liver microsomes. Xenobiotica 33:8, pages 841-854.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
Articles from other publishers (25)
Lesetja R. Motadi, Mpho S. Choene & Nonkululeko N. Mthembu. (2020) Anticancer properties of Tulbaghia violacea regulate the expression of p53-dependent mechanisms in cancer cell lines. Scientific Reports 10:1.
Crossref
Crossref
Hong-Mei Zhang, Guang-Chen Liu, Yang-Fang He, Wei Zhou & Ji-Qiu Hou. (2019) Liver Injury Induced by the Interaction Between Fluoxetine and Celecoxib: A Case Report and the Literature Review. Iranian Red Crescent Medical Journal 21:9.
Crossref
Crossref
Pius Fasinu, Yahya E. Choonara, Riaz A. Khan, Lisa C. Du Toit, Pradeep Kumar, Valence M. K. Ndesendo & Viness Pillay. (2013) Flavonoids and Polymer Derivatives as CYP3A4 Inhibitors for Improved Oral Drug Bioavailability. Journal of Pharmaceutical Sciences 102:2, pages 541-555.
Crossref
Crossref
Andrés Parra, Aránzazu Ferrer-Añó, Cristina Fuentes, Santiago Monleón & Concepción Vinader-Caerols. (2010) Effects of co-administration of amitriptyline and fluoxetine on inhibitory avoidance in mice. Behavioural Brain Research 214:2, pages 343-348.
Crossref
Crossref
. 2010. Mixture Toxicity. Mixture Toxicity
229
269
.
Sami Haddad, Patrick Poulin & Christoph Funk. (2010) Extrapolating In vitro Metabolic Interactions to Isolated Perfused Liver: Predictions of Metabolic Interactions between R-Bufuralol, Bunitrolol, and Debrisoquine. Journal of Pharmaceutical Sciences 99:10, pages 4406-4426.
Crossref
Crossref
Jiangeng Huang, Sai Praneeth R. Bathena & Yazen Alnouti. (2010) Metabolite Profiling of Praziquantel and its Analogs During the Analysis of in vitro Metabolic Stability Using Information-Dependent Acquisition on a Hybrid Triple Quadrupole Linear Ion Trap Mass Spectrometer. Drug Metabolism and Pharmacokinetics 25:5, pages 487-499.
Crossref
Crossref
Olavi Pelkonen, Miia Turpeinen, Jukka Hakkola, Paavo Honkakoski, Janne Hukkanen & Hannu Raunio. (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Archives of Toxicology 82:10, pages 667-715.
Crossref
Crossref
G de J García-Rivas, K Carvajal, F Correa & C Zazueta. (2006)
Ru
360
, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats
in vivo
. British Journal of Pharmacology 149:7, pages 829-837.
Crossref
Crossref
Maria B. Raeder, Johan Fernø, Audun O. Vik-Mo & Vidar M. Steen. (2006) SREBP Activation by Antipsychotic- and Antidepressant-Drugs in Cultured Human Liver Cells: Relevance for Metabolic Side-Effects?. Molecular and Cellular Biochemistry 289:1-2, pages 167-173.
Crossref
Crossref
Verawan Uchaipichat, Leanne K. Winner, Peter I. Mackenzie, David J. Elliot, J Andrew Williams & John O. Miners. (2006)
Quantitative prediction of
in vivo
inhibitory interactions involving glucuronidated drugs from
in vitro
data: the effect of fluconazole on zidovudine glucuronidation
. British Journal of Clinical Pharmacology 61:4, pages 427-439.
Crossref
Crossref
Eveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, Chin B Eap & Pierre Baumann. (2006) Therapeutic Drug Monitoring and Pharmacogenetic Tests as Tools in Pharmacovigilance. Drug Safety 29:9, pages 735-768.
Crossref
Crossref
D. K. Walker. (2004) The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development. British Journal of Clinical Pharmacology 58:6, pages 601-608.
Crossref
Crossref
Stanislav Micuda, Lucie Mundlova, Eva Anzenbacherova, Pavel Anzenbacher, Jaroslav Chladek, Leos Fuksa & Jirina Martinkova. (2004) Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions. European Journal of Clinical Pharmacology 60:8, pages 583-589.
Crossref
Crossref
Kristian Linnet. (2004)
In vitro
microsomal metabolism of imipramine under conditions mimicking the
in vivo
steady‐state situation
. Human Psychopharmacology: Clinical and Experimental 19:1, pages 31-36.
Crossref
Crossref
Weisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag & David B. West. (2003) A TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENE. Drug Metabolism and Disposition 31:8, pages 1054-1064.
Crossref
Crossref
John M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly & William F. Trager. (2003)
K
I
IV, AN IN VIVO PARAMETER FOR PREDICTING THE
MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME
INHIBITION
. Drug Metabolism and Disposition 31:8, pages 1043-1048.
Crossref
Crossref
Caiping Yao, Kent L. Kunze, William F. Trager, Evan D. Kharasch & René H. Levy. (2003) Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19. Drug Metabolism and Disposition 31:5, pages 565-571.
Crossref
Crossref
Caiping Yao & René H. Levy. (2002) Inhibition‐Based Metabolic Drug–Drug Interactions: Predictions from In Vitro Data. Journal of Pharmaceutical Sciences 91:9, pages 1923-1935.
Crossref
Crossref
Lesley M Arnold, Evelyn V Hess, James I Hudson, Jeffrey A Welge, Sarah E Berno & Paul E KeckJrJr. (2002) A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. The American Journal of Medicine 112:3, pages 191-197.
Crossref
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (2013) Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models. The Journal of Clinical Pharmacology 41:11, pages 1149-1179.
Crossref
Crossref
Ilona Kariv, Mark P. Fereshteh & Kevin R. Oldenburg. (2001) Development of a Miniaturized 384-Well High Throughput Screen for the Detection of Substrates of Cytochrome P450 2D6 and 3A4 Metabolism. SLAS Discovery 6:2, pages 91-99.
Crossref
Crossref
J. Fang, G. Mckay, J. W. Hubbard, E. M. Hawes & K. K. Midha. (2001) Dose staggering as a strategy to reduce drug–drug interactions due to reversible enzyme inhibition between orally administered drugs with high first pass effect: a computer simulation study. Biopharmaceutics & Drug Disposition 21:7, pages 249-259.
Crossref
Crossref
Ross A McKinnon & Allan M Evans. (2000) Cytochrome P450 3. Clinically Significant Drug Interactions. The Australian Journal of Hospital Pharmacy 30:4, pages 146-149.
Crossref
Crossref
David J. Greenblatt, Lisa L. von Moltke, Jerold S. Harmatz & Richard I. Shader. (1999) Human Cytochromes and Some Newer Antidepressants: Kinetics, Metabolism, and Drug Interactions. Journal of Clinical Psychopharmacology 19, pages 23S-35S.
Crossref
Crossref